Why the study?
Amiodarone-induced thyrotoxicosis can be difficult to treat due to amiodarone's long half-life causing persistent effects on thyroid function.
Does plasmapheresis improve clinical and biochemical parameters in a patient with medically refractory amiodarone-induced thyrotoxicosis?
Does plasmapheresis improve clinical and biochemical parameters in a patient with medically refractory amiodarone-induced thyrotoxicosis?
Plasmapheresis can effectively rapidly lower circulating thyroid hormones and safely bridge patients with refractory amiodarone-induced thyrotoxicosis to definitive surgical treatment.
Amiodarone-induced thyrotoxicosis (AIT) can be difficult to treat since amiodarone's long half-life leads to a persistent effect on thyroid function. We present a case of a 74-year-old male with severe AIT who presented with altered mentation and ultimately required intubation and intensive care for management of thyroid storm. Standard medical therapy for treatment of thyroid storm was initiated immediately, but the patient remained unresponsive with worsening biochemical parameters with increasing total T3 levels and sustained elevated levels of free T4 after 5 days of medical management. Due to the lack of a clinical and biochemical response to conventional medical therapy, the patient was started on plasmapheresis and underwent a total of 7 cycles of plasmapheresis over a period of 10 days. He significantly improved with plasmapheresis and was successfully bridged to a total thyroidectomy, which was completed without complications.
No takes yet. Share an insight, caveat, or question.
Moazezi et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: